Medicinal cannabis trial recruiting patients

Published 5th December, 2016 in Health

The clinical trial will involve 80 patients in the first stage and could expand to another 250 patients across NSW.

Medicinal cannabis capsules

Doctors are recruiting patients in a world-first medicinal cannabis trial in NSW for the prevention of chemotherapy-induced nausea and vomiting.

One-third of patients continue to suffer from chemotherapy-induced nausea and vomiting after being prescribed conventional anti-nausea medication.

Minister for Medical Research Pru Goward said this was the largest and most definitive trial ever conducted in the world of a plant-derived cannabis medicine for the prevention of nausea and vomiting in chemotherapy patients.

“The trial will play a critical role in developing a better understanding of how cannabis products may provide relief for cancer patients,” Ms Goward said. 

The trial is part of the NSW Government’s commitment to support medicinal cannabis clinical trials and reforms.

The trial will be using an oral plant-derived, pharmaceutical-grade capsule containing equal amounts of Tetrahydrocannabinol (THC) and Cannabidiol (CBD), developed and supplied by Canadian company Tilray.

Find out more about the clinical trial for patients with chemotherapy-induced nausea and vomiting

Published 5th December, 2016 in Health